Reference number : 236-2015-2016-Q1-00154, amendment number : , agreement type : G, recipient legal name : Karniychuk, Uladzimir, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 116250.0, agreement start date : 2015-04-01, agreement end date : 2016-01-13, description english : Targeted intrapulmonary delivery of antiviral and immunomodulatory therapeutics to alleviate severe experimental H7N9 influenza-induced pneumonia, description french : Targeted intrapulmonary delivery of antiviral and immunomodulatory therapeutics to alleviate severe experimental H7N9 influenza-induced pneumonia, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2017-18)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2017-18)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada